Skip to main content

Henry Schein Inc(HSIC-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low76.25
Day High79.07
Open:78.33
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Henry Schein Inc

Select a category then submit the form to load news
StockStory
3 Cash-Producing Stocks We’re Skeptical Of
SMPL
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC), Dyadic International (DYAI) and Bioventus (BVS)
Motley Fool
BlackLine Stock Down Nearly 30% as One Fund Cuts Stake by $10 Million
Motley Fool
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares?
StockStory
3 Profitable Stocks We Approach with Caution
DRS
Tipranks
Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC) and Amphastar Pharmaceuticals (AMPH)
Tipranks
Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC)
GlobeNewswire
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
Tipranks
Barclays Sticks to Their Buy Rating for Henry Schein (HSIC)
Tipranks
Henry Schein Balances Strong Growth With Margin Pressure
Tipranks
Analysts Conflicted on These Healthcare Names: Elanco Animal Health (ELAN) and Henry Schein (HSIC)
Tipranks
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC)
Tipranks
Evercore ISI Remains a Buy on Henry Schein (HSIC)
StockStory
Henry Schein (HSIC) Stock Trades Up, Here Is Why
HSIC
Tipranks
Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Delcath Systems (DCTH) and Certara (CERT)
Motley Fool
Henry Schein (HSIC) Q4 2025 Earnings Transcript
StockStory
Henry Schein’s (NASDAQ:HSIC) Q4 CY2025 Sales Beat Estimates
HSIC
Tipranks
Robert W. Baird upgrades Henry Schein (HSIC) to a Buy
StockStory
Earnings To Watch: Henry Schein (HSIC) Reports Q4 Results Tomorrow
HSIC
StockStory
1 Safe-and-Steady Stock with Solid Fundamentals and 2 That Underwhelm
AME
StockStory
3 Value Stocks That Fall Short
SWKS
Tipranks
Analysts Offer Insights on Healthcare Companies: Henry Schein (HSIC) and Azenta (AZTA)
StockStory
1 S&P 500 Stock on Our Buy List and 2 That Underwhelm
DG
Tipranks
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Agios Pharma (AGIO) and Henry Schein (HSIC)
Tipranks
Henry Schein (HSIC) Gets a Hold from Mizuho Securities
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Henry Schein (HSIC), Boston Scientific (BSX)
Tipranks
Henry Schein (HSIC) Receives a Buy from Evercore ISI
StockStory
3 Reasons to Sell HSIC and 1 Stock to Buy Instead
HSIC
Tipranks
Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Henry Schein (HSIC) and NovoCure (NVCR)
Tipranks
Henry Schein appoints new CEO amid governance changes
Tipranks
Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC)
Motley Fool
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan

Profile

Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.